A novel transgenic rat model with a full alzheimer's - Like amyloid pathology displays pre - Plaque intracellular amyloid -β- Associated cognitive impairment

Journal of Alzheimer's Disease

Volumn 20, Issue 1, 2010, Pages 113-126

  Leon, Wanda Carolina ^a   Canneva, Fabio ^a   Partridge, Vanessa ^a   Allard, Simon ^a   Ferretti, Maria Teresa ^a   Dewilde, Arald ^a   Vercauteren, Freya ^a   Atifeh, Ramtin ^a   Ducatenzeiler, Adriana ^a   Klein, William ^b   Szyf, Moshe ^a   Alhonen, Leena ^c   Cuello, A Claudio ^a  

^a MCGILL UNIVERSITY   (Canada)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Alzheimer's disease; amyloid oligomers; cognitive impairment; intracellular amyloid ; transgenic rat

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; COGNITIVE DEFECT; CONTROLLED STUDY; DENTATE GYRUS; EXPERIMENTAL MODEL; FEMALE; GENE EXPRESSION; GLIA; HIPPOCAMPUS; IMMUNOREACTIVITY; MALE; MAZE TEST; MCGILL R THY1 APP RAT; NEURITE; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; RAT; TRANSGENIC RAT;

EID: 77953020162     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-1349     Document Type: Article

References (55)

1. Selkoe DJ (1991) Alzheimer's disease: In the beginning. Nature 354, 432-433.
2. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298, 789-791.
3. Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C (1992) Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 359, 325-327.
4. Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, Sisodia S, Malinow R (2003) APP processing and synaptic function. Neuron 37, 925-937.
5. Hardy JA, Goate AM, Owen MJ, Mullan MJ, Rossor MN, Pearson RC (1989) Modelling the occurrence and pathology of Alzheimer's disease. Neurobiol Aging 10, 429-431.
6. Hardy JA, Owen MJ, Goate AM, James LA, Haynes AR, Rossor MN, Roques P, Mullan MJ (1989) Molecular genetics of Alzheimer's disease. Biochem Soc Trans 17, 5-6.
7. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagoplan S, Johnson-Wood K, Khan K, Lee M, Liebowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J (1995) Alzheimertype neuropathology in transgenic mice overexpressingV717F beta-amyloid precursor protein. Nature 373, 523-527.
8. Janus C, Westaway D (2001) Transgenic mouse models of Alzheimer's disease. Physiol Behav 73, 873-886.
9. McGowan E, Eriksen J, Hutton M (2006) A decade of modeling Alzheimer's disease in transgenic mice. Trends Genet 22, 281-289.
10. Eriksen JL, Janus CG (2007) Plaques, tangles, and memory loss in mouse models of neurodegeneration. Behav Genet 37, 79-100.
11. Kolb B, Whishaw IQ (2001) Introduction to brain and behavior. W.H Freeman & Co, New York, NY.
12. Echeverria V, Ducatenzeiler A, Alhonen L, Janne J, Grant SM, Wandosell F, Muro A, Baralle F, Li H, Duff K, Szyf M, Cuello AC (2004) Rat transgenic models with a phenotype of intracellular Abeta accumulation in hippocampus and cortex. J Alzheimers Dis 6, 209-219.
13. Ruiz-Opazo N, Kosik KS, Lopez LV, Bagamasbad P, Ponce LR, Herrera VL (2004) Attenuated hippocampus-dependent learning and memory decline in transgenic TgAPPswe Fischer-344 rats. Mol Med 10, 36-44.
14. Folkesson R, Malkiewicz K, Kloskowska E, Nilsson T, Popova E, Bogdanovic N, Ganten U, Ganten D, Bader M, Winblad B, Benedikz E (2007) A transgenic rat expressing human APP with the Swedish Alzheimer's disease mutation. Biochem Biophys Res Commun 358, 777-782.
15. Lopez EM, Bell KF, Ribeiro-da-Silva A, Cuello AC (2004) Early changes in neurons of the hippocampus and neocortex in transgenic rats expressing intracellular human a-beta. J Alzheimers Dis 6, 421-431.
16. Vercauteren FG, Clerens S, Roy L, Hamel N, Arckens L, Vandesande F, Alhonen L, Janne J, Szyf M, Cuello AC (2004) Early dysregulation of hippocampal proteins in transgenic rats with Alzheimer's disease-linked mutations in amyloid precursor protein and presenilin 1. Brain Res Mol Brain Res 132, 241-259.
17. Echeverria V, Ducatenzeiler A, Dowd E, Janne J, Grant SM, Szyf M, Wandosell F, Avila J, Grimm H, Dunnett SB, Hartmann T, Alhonen L, Cuello AC (2004) Altered mitogenactivated protein kinase signaling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the beta-amyloid peptide intracellularly in hippocampal and cortical neurons. Neuroscience 129, 583-592.
18. Flood DG, Lin YG, Lang DM, Trusko SP, Hirsch JD, Savage MJ, Scott RW, Howland DS (2007) A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition. Neurobiol Aging 30, 1078-1090.
19. Liu L, Orozco IJ, Planel E, Wen Y, Bretteville A, Krishnamurthy P, Wang L, Herman M, Figueroa H, Yu WH, Arancio O, Duff K (2008) A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment. Neurobiol Dis 31, 46-57.
20. Gordon JW, Scangos GA, Plotkin DJ, Barbosa JA, Ruddle FH (1980) Genetic transformation of mouse embryos by microinjection of purified DNA. Proc Natl Acad Sci U S A 77, 7380-7384.
21. Van der Putten H,Wiederhold KH, Probst A, Barbieri S, Mistl C, Danner S, Kauffmann S, Hofele K, Spooren WP, Ruegg MA, Lin S, Caroni P, Sommer B, Tolnay M, Bilbe G (2000) Neuropathology in mice expressing human alpha-synuclein. J Neurosci 20, 6021-6029.
22. Luthi A, Van der Putten H, Botteri FM, Mansuy IM, Meins M, Frey U, Sansig G, Portet C, Schmutz M, Schroder M, Nitsch C, Laurent JP, Monard D (1997) Endogenous serine protease inhibitor modulates epileptic activity and hippocampal longterm potentiation. J Neurosci 17, 4688-4699.
23. Mullan M, Crawford F, Axelman K, Houlden H, Lilius L,Winblad B, Lannfelt L (1992) A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1, 345-347.
24. Murrell J, FarlowM, Ghetti B, Benson MD(1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254, 97-99.
25. Semenenko FM, Bramwell S, Sidebottom E, CuelloAC(1985) Development of a mouse antiperoxidase secreting hybridoma for use in the production of a mouse PAP complex for immunocytochemistry and as a parent cell line in the development of hybrid hybridomas. Histochemistry 83, 405-408.
26. Grant SM, Ducatenzeiler A, Szyf M, Cuello AC (2000) Abeta immunoreactive material is present in several intracellular compartments in transfected, neuronally differentiated, P19 cells expressing the human amyloid beta-protein precursor. J Alzheimers Dis 2, 207-222.
27. Lambert MP, Velasco PT, Chang L, Viola KL, Fernandez S, Lacor PN, Khuon D, Gong Y, Bigio EH, Shaw P, De Felice FG, Krafft GA, Klein WL (2007) Monoclonal antibodies that target pathological assemblies of Abeta. J Neurochem 100, 23-35.
28. Gilmor ML, Nash NR, Roghani A, Edwards RH, Yi H, Hersch SM, Levey AI (1996) Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles. J Neurosci 16, 2179-2190.
29. Bell KF, Ducatenzeiler A, Ribeiro-da-Silva A, Duff K, Bennett DA, Cuello AC (2006) The amyloid pathology progresses in a neurotransmitter-specific manner. Neurobiol Aging 27, 1644-1657.
30. Hu L, Wong TP, Cote SL, Bell KF, Cuello AC (2003) The impact of Abeta-plaques on cortical cholinergic and noncholinergic presynaptic boutons in alzheimer's disease-like transgenic mice. Neuroscience 121, 421-432.
31. Morris RGM, Garrud P, Rawlins JNP, O'Keefe J (1982) Place navigation in rats with hippocampal lesions. Nature 297, 681-683.
32. Garofalo L, Cuello AC (1994) Nerve growth factor and the monosialoganglioside GM1: analogous and different in vivo effects on biochemical, morphological, and behavioral parameters of adult cortically lesioned rats. Exp Neurol 125, 195-217.
33. Garofalo L, Elliott PJ, Cuello AC (1992) Behavioral response of rats with cortical lesions to cholinomimetics. Physiol Behav 52, 971-977.
34. Garofalo L, Cuello AC (1990) Nerve growth factor and the monosialogangliosideGM1modulate cholinergic markers and affect behavior of decorticated adult rats. Eur J Pharmacol 183, 934-935.
35. Kolb B, Sutherland RJ, Whishaw IQ (1983) A comparison of the contributions of the frontal and parietal association cortex to spatial localization in rats. Behav Neurosci 97, 13-27.
36. Folkesson R, Malkiewicz K, Kloskowska E, Nilsson T, Popova E, Bogdanovic N, Ganten U, Ganten D, Bader M, Winblad B, Benedikz E (2007) A transgenic rat expressing human APP with the Swedish Alzheimer's disease mutation. Biochem Biophys Res Commun 358, 777-782.
37. Ruiz-Opazo N, Kosik KS, Lopez LV, Bagamasbad P, Ponce LR, Herrera VL (2004) Attenuated hippocampus-dependent learning and memory decline in transgenic TgAPPswe Fischer-344 rats. Mol Med 10, 36-44.
38. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, et al. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760.
39. Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, Greenfield JP, Haroutunian V, Buxbaum JD, Xu H, Greengard P, Relkin NR (2000) Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 156, 15-20.
40. D'Andrea MR, Nagele RG, Wang HY, Lee DH (2002) Consistent immunohistochemical detection of intracellular betaamyloid42 in pyramidal neurons of Alzheimer's disease entorhinal cortex. Neurosci Lett 333, 163-166.
41. Fernandez-Vizarra P, Fernandez AP, Castro-Blanco S, Serrano J, Bentura ML, Martinez-Murillo R, Martinez A, Rodrigo J (2004) Intra- and extracellular Abeta and PHF in clinically evaluated cases of Alzheimer's disease. Histol Histopathol 19, 823-844. (Pubitemid 38855065)
42. Mori C, Spooner ET, Wisniewsk KE, Wisniewski TM, Yamaguch H, Saido TC, Tolan DR, Selkoe DJ, Lemere CA (2002) Intraneuronal Abeta42 accumulation inDownsyndrome brain. Amyloid 9, 88-102.
43. LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloidbeta in Alzheimer's disease. Nat Rev Neurosci 8, 499-509.
44. D'Andrea MR, Nagele RG, Wang HY, Peterson PA, Lee DH (2001) Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology 38, 120-134.
45. McGeer PL, Akiyama H, Itagaki S, McGeer EG (1989) Immune system response in Alzheimer's disease. Can J Neurol Sci 16, 516-527.
46. D'Andrea MR, Cole GM, Ard MD (2004) The microglial phagocytic role with specific plaque types in the Alzheimer disease brain. Neurobiol Aging 25, 675-683.
47. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539.
48. Cleary JP,Walsh DM, Hofmeister JJ, Shankar GM,Kuskowski MA, Selkoe DJ, Ashe KH (2005) Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8, 79-84.
49. Selkoe DJ (2008) Soluble oligomers of the amyloid betaprotein impair synaptic plasticity and behavior. Behav Brain Res 192, 106-113.
50. Townsend M, Mehta T, Selkoe DJ (2007) Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway. J Biol Chem 282, 33305-33312.
51. Tong L, Thornton PL, Balazs R, Cotman CW (2001) Beta -amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival is not compromised. J Biol Chem 276, 17301-17306.
52. Echeverria V, Ducatenzeiler A, Chen CH, Cuello AC (2005) Endogenous beta-amyloid peptide synthesis modulates cAMP response element-regulated gene expression in PC12 cells. Neuroscience 135, 1193-1202.
53. Ma QL, Harris-White ME, Ubeda OJ, Simmons M, Beech W, Lim GP, Teter B, Frautschy SA, Cole GM (2007) Evidence of Abeta- and transgene-dependent defects in ERK-CREB signaling in Alzheimer's models. J Neurochem 103, 1594-1607
54. Arvanitis DN, Ducatenzeiler A, Ou JN, Grodstein E, Andrews SD, Tendulkar SR, Ribeiro-da-Silva A, Szyf M, Cuello AC (2007) High intracellular concentrations of amyloidbeta block nuclear translocation of phosphorylated CREB. J Neurochem 103, 216-228.
55. Breitner JC, Haneuse SJ,Walker R, Dublin S, Crane PK, Gray SL, Larson EB (2009) Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort. Neurology 72, 1899-1905.